Cell Screen SA (CeSSA) is a professional research facility dedicated to High Throughput Screening (HTS) focused on supporting researchers and industry on biomedical innovations and discovery.
CeSSA was established in 2016 through a joint ARC Linkage Infrastructure, Equipment and Facilities (LIEF) application across the South Australian universities. CeSSA is a Therapeutic Innovation Australia approved Accelerator Pipeline facility (TIA capabilities), enabling support for therapeutic discovery projects.
Located in the Flinders Centre for Innovation in Cancer (FCIC) and under the Flinders Health and Medical Research Institute (FHMRI), Flinders University, CeSSA is a fee-for-service facility run by our team of experienced staff. Equipped with a unique set of instruments integrated by a robot arm in an automated platform, the facility provides HTS of compounds or RNAi on cell-culture or enzymatic-based models of disease. We work with academia and industry to run screening projects with established assays using either a plate reader (Ensight) or high content imaging (Operetta) endpoint.
Cell Screen SA staff and associated researchers also support grant applications with project plans, support letters, budgets, and trial experiments.